Global Oncology Drugs Market Size, Status and Forecast 2021-2027

Q: Who are the key players in the oncology drugs market?

Some of the key players are Roche, Hengrui, Astrazeneca plc, Qilu, Sanofi, HANSOH, LUYE, Novartis, GuiZhou YiBai, Lunan, Eli Lilly and Company, Others.

Code: QYRE-Auto-4R430

Report

June 2021

125 Pages

QYResearch

Region: Global, Central & South America, North America, Europe, Asia Pacific, Middle East, Africa,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Roche

Hengrui

Astrazeneca plc

Qilu

Sanofi

HANSOH

LUYE

Novartis

GuiZhou YiBai

Lunan

Eli Lilly and Company

Celgene

Bristol–Myers Squibb

Johnson & Johnson

Merck

Pfizer Inc

Amgen Inc

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen S A

Bayer

Biogen Idec

TEVA

Otsuka

Eisai Co Ltd

Merck KGaA

Gilead Sciences

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.

The industry's leading producers include Roche, Celgene and Novartis, which together account for 35.56% of their 2019 revenues. By region, North America had the highest share of income in 2019, at 43.61%.

Market Analysis and Insights: Global Oncology Drugs Market

The global Oncology Drugs market size is projected to reach US$ 354330 million by 2027, from US$ 178590 million in 2020, at a CAGR of 10.3% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Drugs market.

Global Oncology Drugs Scope and Market Size

Oncology Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019.

Segment by Application

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

BY COMPANY

Roche

Celgene

Novartis

Bristol-Myers Squibb

Johnson & Johnson

Merck & Co.

AstraZeneca

Pfizer

Amgen

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen

Sanofi

Bayer

Biogen Idec

Teva

Otsuka

Eisai

Merck KGaA

Gilead Sciences

FEATURED COMPANIES

Roche

Hengrui

Astrazeneca plc

Qilu

Sanofi

HANSOH

LUYE

Novartis

GuiZhou YiBai

Lunan

Eli Lilly and Company

Celgene

Bristol–Myers Squibb

Johnson & Johnson

Merck

Pfizer Inc

Amgen Inc

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen S A

Bayer

Biogen Idec

TEVA

Otsuka

Eisai Co Ltd

Merck KGaA

Gilead Sciences

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Chemotherapy

1.2.3 Targeted Therapy

1.2.4 Immunotherapy (Biologic Therapy)

1.2.5 Hormonal Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Blood Cancer

1.3.3 Breast Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Prostate Cancer

1.3.6 Respiratory or Lung Cancer

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Oncology Drugs Market Perspective (2016-2027)

2.2 Oncology Drugs Growth Trends by Regions

2.2.1 Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Oncology Drugs Historic Market Share by Regions (2016-2021)

2.2.3 Oncology Drugs Forecasted Market Size by Regions (2022-2027)

2.3 Oncology Drugs Industry Dynamic

2.3.1 Oncology Drugs Market Trends

2.3.2 Oncology Drugs Market Drivers

2.3.3 Oncology Drugs Market Challenges

2.3.4 Oncology Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Drugs Players by Revenue

3.1.1 Global Top Oncology Drugs Players by Revenue (2016-2021)

3.1.2 Global Oncology Drugs Revenue Market Share by Players (2016-2021)

3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Oncology Drugs Revenue

3.4 Global Oncology Drugs Market Concentration Ratio

3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2020

3.5 Oncology Drugs Key Players Head office and Area Served

3.6 Key Players Oncology Drugs Product Solution and Service

3.7 Date of Enter into Oncology Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Drugs Breakdown Data by Type

4.1 Global Oncology Drugs Historic Market Size by Type (2016-2021)

4.2 Global Oncology Drugs Forecasted Market Size by Type (2022-2027)

5 Oncology Drugs Breakdown Data by Application

5.1 Global Oncology Drugs Historic Market Size by Application (2016-2021)

5.2 Global Oncology Drugs Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Oncology Drugs Market Size (2016-2027)

6.2 North America Oncology Drugs Market Size by Type

6.2.1 North America Oncology Drugs Market Size by Type (2016-2021)

6.2.2 North America Oncology Drugs Market Size by Type (2022-2027)

6.2.3 North America Oncology Drugs Market Size by Type (2016-2027)

6.3 North America Oncology Drugs Market Size by Application

6.3.1 North America Oncology Drugs Market Size by Application (2016-2021)

6.3.2 North America Oncology Drugs Market Size by Application (2022-2027)

6.3.3 North America Oncology Drugs Market Size by Application (2016-2027)

6.4 North America Oncology Drugs Market Size by Country

6.4.1 North America Oncology Drugs Market Size by Country (2016-2021)

6.4.2 North America Oncology Drugs Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Oncology Drugs Market Size (2016-2027)

7.2 Europe Oncology Drugs Market Size by Type

7.2.1 Europe Oncology Drugs Market Size by Type (2016-2021)

7.2.2 Europe Oncology Drugs Market Size by Type (2022-2027)

7.2.3 Europe Oncology Drugs Market Size by Type (2016-2027)

7.3 Europe Oncology Drugs Market Size by Application

7.3.1 Europe Oncology Drugs Market Size by Application (2016-2021)

7.3.2 Europe Oncology Drugs Market Size by Application (2022-2027)

7.3.3 Europe Oncology Drugs Market Size by Application (2016-2027)

7.4 Europe Oncology Drugs Market Size by Country

7.4.1 Europe Oncology Drugs Market Size by Country (2016-2021)

7.4.2 Europe Oncology Drugs Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Oncology Drugs Market Size (2016-2027)

8.2 Asia-Pacific Oncology Drugs Market Size by Type

8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Oncology Drugs Market Size by Type (2016-2027)

8.3 Asia-Pacific Oncology Drugs Market Size by Application

8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Oncology Drugs Market Size by Application (2016-2027)

8.4 Asia-Pacific Oncology Drugs Market Size by Region

8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Oncology Drugs Market Size (2016-2027)

9.2 Latin America Oncology Drugs Market Size by Type

9.2.1 Latin America Oncology Drugs Market Size by Type (2016-2021)

9.2.2 Latin America Oncology Drugs Market Size by Type (2022-2027)

9.2.3 Latin America Oncology Drugs Market Size by Type (2016-2027)

9.3 Latin America Oncology Drugs Market Size by Application

9.3.1 Latin America Oncology Drugs Market Size by Application (2016-2021)

9.3.2 Latin America Oncology Drugs Market Size by Application (2022-2027)

9.3.3 Latin America Oncology Drugs Market Size by Application (2016-2027)

9.4 Latin America Oncology Drugs Market Size by Country

9.4.1 Latin America Oncology Drugs Market Size by Country (2016-2021)

9.4.2 Latin America Oncology Drugs Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Drugs Market Size (2016-2027)

10.2 Middle East & Africa Oncology Drugs Market Size by Type

10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Oncology Drugs Market Size by Type (2016-2027)

10.3 Middle East & Africa Oncology Drugs Market Size by Application

10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2027)

10.4 Middle East & Africa Oncology Drugs Market Size by Country

10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Oncology Drugs Introduction

11.1.4 Roche Revenue in Oncology Drugs Business (2016-2021)

11.1.5 Roche Recent Development

11.2 Celgene

11.2.1 Celgene Company Details

11.2.2 Celgene Business Overview

11.2.3 Celgene Oncology Drugs Introduction

11.2.4 Celgene Revenue in Oncology Drugs Business (2016-2021)

11.2.5 Celgene Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Oncology Drugs Introduction

11.3.4 Novartis Revenue in Oncology Drugs Business (2016-2021)

11.3.5 Novartis Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Details

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction

11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Oncology Drugs Introduction

11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021)

11.5.5 Johnson & Johnson Recent Development

11.6 Merck & Co.

11.6.1 Merck & Co. Company Details

11.6.2 Merck & Co. Business Overview

11.6.3 Merck & Co. Oncology Drugs Introduction

11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2016-2021)

11.6.5 Merck & Co. Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Oncology Drugs Introduction

11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2016-2021)

11.7.5 AstraZeneca Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Oncology Drugs Introduction

11.8.4 Pfizer Revenue in Oncology Drugs Business (2016-2021)

11.8.5 Pfizer Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Oncology Drugs Introduction

11.9.4 Amgen Revenue in Oncology Drugs Business (2016-2021)

11.9.5 Amgen Recent Development

11.10 Eli Lilly

11.10.1 Eli Lilly Company Details

11.10.2 Eli Lilly Business Overview

11.10.3 Eli Lilly Oncology Drugs Introduction

11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2016-2021)

11.10.5 Eli Lilly Recent Development

11.11 AbbVie

11.11.1 AbbVie Company Details

11.11.2 AbbVie Business Overview

11.11.3 AbbVie Oncology Drugs Introduction

11.11.4 AbbVie Revenue in Oncology Drugs Business (2016-2021)

11.11.5 AbbVie Recent Development

11.12 Takeda

11.12.1 Takeda Company Details

11.12.2 Takeda Business Overview

11.12.3 Takeda Oncology Drugs Introduction

11.12.4 Takeda Revenue in Oncology Drugs Business (2016-2021)

11.12.5 Takeda Recent Development

11.13 Astellas

11.13.1 Astellas Company Details

11.13.2 Astellas Business Overview

11.13.3 Astellas Oncology Drugs Introduction

11.13.4 Astellas Revenue in Oncology Drugs Business (2016-2021)

11.13.5 Astellas Recent Development

11.14 Ipsen

11.14.1 Ipsen Company Details

11.14.2 Ipsen Business Overview

11.14.3 Ipsen Oncology Drugs Introduction

11.14.4 Ipsen Revenue in Oncology Drugs Business (2016-2021)

11.14.5 Ipsen Recent Development

11.15 Sanofi

11.15.1 Sanofi Company Details

11.15.2 Sanofi Business Overview

11.15.3 Sanofi Oncology Drugs Introduction

11.15.4 Sanofi Revenue in Oncology Drugs Business (2016-2021)

11.15.5 Sanofi Recent Development

11.16 Bayer

11.16.1 Bayer Company Details

11.16.2 Bayer Business Overview

11.16.3 Bayer Oncology Drugs Introduction

11.16.4 Bayer Revenue in Oncology Drugs Business (2016-2021)

11.16.5 Bayer Recent Development

11.17 Biogen Idec

11.17.1 Biogen Idec Company Details

11.17.2 Biogen Idec Business Overview

11.17.3 Biogen Idec Oncology Drugs Introduction

11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2016-2021)

11.17.5 Biogen Idec Recent Development

11.18 Teva

11.18.1 Teva Company Details

11.18.2 Teva Business Overview

11.18.3 Teva Oncology Drugs Introduction

11.18.4 Teva Revenue in Oncology Drugs Business (2016-2021)

11.18.5 Teva Recent Development

11.18 Otsuka

.1 Otsuka Company Details

.2 Otsuka Business Overview

.3 Otsuka Oncology Drugs Introduction

.4 Otsuka Revenue in Oncology Drugs Business (2016-2021)

.5 Otsuka Recent Development

11.20 Eisai

11.20.1 Eisai Company Details

11.20.2 Eisai Business Overview

11.20.3 Eisai Oncology Drugs Introduction

11.20.4 Eisai Revenue in Oncology Drugs Business (2016-2021)

11.20.5 Eisai Recent Development

11.21 Merck KGaA

11.21.1 Merck KGaA Company Details

11.21.2 Merck KGaA Business Overview

11.21.3 Merck KGaA Oncology Drugs Introduction

11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2016-2021)

11.21.5 Merck KGaA Recent Development

11.22 Gilead Sciences

11.22.1 Gilead Sciences Company Details

11.22.2 Gilead Sciences Business Overview

11.22.3 Gilead Sciences Oncology Drugs Introduction

11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2016-2021)

11.22.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Hengrui

Astrazeneca plc

Qilu

Sanofi

HANSOH

LUYE

Novartis

GuiZhou YiBai

Lunan

Eli Lilly and Company

Celgene

Bristol–Myers Squibb

Johnson & Johnson

Merck

Pfizer Inc

Amgen Inc

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen S A

Bayer

Biogen Idec

TEVA

Otsuka

Eisai Co Ltd

Merck KGaA

Gilead Sciences

List of Tables

Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Chemotherapy

Table 3. Key Players of Targeted Therapy

Table 4. Key Players of Immunotherapy (Biologic Therapy)

Table 5. Key Players of Hormonal Therapy

Table 6. Key Players of Others

Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 8. Global Oncology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 9. Global Oncology Drugs Market Size by Regions (2016-2021) & (US$ Million)

Table 10. Global Oncology Drugs Market Share by Regions (2016-2021)

Table 11. Global Oncology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 12. Global Oncology Drugs Market Share by Regions (2022-2027)

Table 13. Oncology Drugs Market Trends

Table 14. Oncology Drugs Market Drivers

Table 15. Oncology Drugs Market Challenges

Table 16. Oncology Drugs Market Restraints

Table 17. Global Oncology Drugs Revenue by Players (2016-2021) & (US$ Million)

Table 18. Global Oncology Drugs Market Share by Players (2016-2021)

Table 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020)

Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2020

Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2016-2021)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Oncology Drugs Product Solution and Service

Table 24. Date of Enter into Oncology Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 27. Global Oncology Drugs Revenue Market Share by Type (2016-2021)

Table 28. Global Oncology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 29. Global Oncology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 30. Global Oncology Drugs Market Size Share by Application (2016-2021) & (US$ Million)

Table 31. Global Oncology Drugs Revenue Market Share by Application (2016-2021)

Table 32. Global Oncology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 33. Global Oncology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 34. North America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 35. North America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)

Table 36. North America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)

Table 37. North America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)

Table 38. North America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)

Table 39. North America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)

Table 40. Europe Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 41. Europe Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)

Table 42. Europe Oncology Drugs Market Size by Application (2016-2021) (US$ Million)

Table 43. Europe Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)

Table 44. Europe Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)

Table 45. Europe Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)

Table 46. Asia-Pacific Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 47. Asia-Pacific Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)

Table 48. Asia-Pacific Oncology Drugs Market Size by Application (2016-2021) (US$ Million)

Table 49. Asia-Pacific Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)

Table 50. Asia-Pacific Oncology Drugs Market Size by Region (2016-2021) & (US$ Million)

Table 51. Asia-Pacific Oncology Drugs Market Size by Region (2022-2027) & (US$ Million)

Table 52. Latin America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 53. Latin America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)

Table 54. Latin America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)

Table 55. Latin America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)

Table 56. Latin America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)

Table 57. Latin America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)

Table 58. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) (US$ Million)

Table 59. Middle East & Africa Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)

Table 60. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) (US$ Million)

Table 61. Middle East & Africa Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)

Table 62. Middle East & Africa Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)

Table 63. Middle East & Africa Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Oncology Drugs Product

Table 67. Roche Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 68. Roche Recent Development

Table 69. Celgene Company Details

Table 70. Celgene Business Overview

Table 71. Celgene Oncology Drugs Product

Table 72. Celgene Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 73. Celgene Recent Development

Table 74. Novartis Company Details

Table 75. Novartis Business Overview

Table 76. Novartis Oncology Drugs Product

Table 77. Novartis Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 78. Novartis Recent Development

Table 79. Bristol-Myers Squibb Company Details

Table 80. Bristol-Myers Squibb Business Overview

Table 81. Bristol-Myers Squibb Oncology Drugs Product

Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 83. Bristol-Myers Squibb Recent Development

Table 84. Johnson & Johnson Company Details

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Oncology Drugs Product

Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 88. Johnson & Johnson Recent Development

Table 89. Merck & Co. Company Details

Table 90. Merck & Co. Business Overview

Table 91. Merck & Co. Oncology Drugs Product

Table 92. Merck & Co. Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 93. Merck & Co. Recent Development

Table 94. AstraZeneca Company Details

Table 95. AstraZeneca Business Overview

Table 96. AstraZeneca Oncology Drugs Product

Table 97. AstraZeneca Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 98. AstraZeneca Recent Development

Table 99. Pfizer Company Details

Table 100. Pfizer Business Overview

Table 101. Pfizer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 102. Pfizer Recent Development

Table 103. Amgen Company Details

Table 104. Amgen Business Overview

Table 105. Amgen Oncology Drugs Product

Table 106. Amgen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 107. Amgen Recent Development

Table 108. Eli Lilly Company Details

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Oncology Drugs Product

Table 111. Eli Lilly Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 112. Eli Lilly Recent Development

Table 113. AbbVie Company Details

Table 114. AbbVie Business Overview

Table 115. AbbVie Oncology Drugs Product

Table 116. AbbVie Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 117. AbbVie Recent Development

Table 118. Takeda Company Details

Table 119. Takeda Business Overview

Table 120. Takeda Oncology Drugs Product

Table 121. Takeda Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 122. Takeda Recent Development

Table 123. Astellas Company Details

Table 124. Astellas Business Overview

Table 125. Astellas Oncology Drugs Product

Table 126. Astellas Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 127. Astellas Recent Development

Table 128. Ipsen Company Details

Table 129. Ipsen Business Overview

Table 130. Ipsen Oncology Drugs Product

Table 131. Ipsen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 132. Ipsen Recent Development

Table 133. Sanofi Company Details

Table 134. Sanofi Business Overview

Table 135. Sanofi Oncology Drugs Product

Table 136. Sanofi Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 137. Sanofi Recent Development

Table 138. Bayer Company Details

Table 139. Bayer Business Overview

Table 140. Bayer Oncology Drugs Product

Table 141. Bayer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 142. Bayer Recent Development

Table 143. Biogen Idec Company Details

Table 144. Biogen Idec Business Overview

Table 145. Biogen Idec Oncology Drugs Product

Table 146. Biogen Idec Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 147. Biogen Idec Recent Development

Table 148. Teva Company Details

Table 149. Teva Business Overview

Table 150. Teva Oncology Drugs Product

Table 151. Teva Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 152. Teva Recent Development

Table 153. Otsuka Company Details

Table 154. Otsuka Business Overview

Table 155. Otsuka Oncology Drugs Product

Table 156. Otsuka Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 157. Otsuka Recent Development

Table 158. Eisai Company Details

Table 159. Eisai Business Overview

Table 160. Eisai Oncology Drugs Product

Table 161. Eisai Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 162. Eisai Recent Development

Table 163. Merck KGaA Company Details

Table 164. Merck KGaA Business Overview

Table 165. Merck KGaA Oncology Drugs Product

Table 166. Merck KGaA Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 167. Merck KGaA Recent Development

Table 168. Gilead Sciences Company Details

Table 169. Gilead Sciences Business Overview

Table 170. Gilead Sciences Oncology Drugs Product

Table 171. Gilead Sciences Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)

Table 172. Gilead Sciences Recent Development

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oncology Drugs Market Share by Type: 2020 VS 2027

Figure 2. Chemotherapy Features

Figure 3. Targeted Therapy Features

Figure 4. Immunotherapy (Biologic Therapy) Features

Figure 5. Hormonal Therapy Features

Figure 6. Others Features

Figure 7. Global Oncology Drugs Market Share by Application: 2020 VS 2027

Figure 8. Blood Cancer Case Studies

Figure 9. Breast Cancer Case Studies

Figure 10. Gastrointestinal Cancer Case Studies

Figure 11. Prostate Cancer Case Studies

Figure 12. Respiratory or Lung Cancer Case Studies

Figure 13. Others Case Studies

Figure 14. Oncology Drugs Report Years Considered

Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 16. Global Oncology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 17. Global Oncology Drugs Market Share by Regions: 2020 VS 2027

Figure 18. Global Oncology Drugs Market Share by Regions (2022-2027)

Figure 19. Global Oncology Drugs Market Share by Players in 2020

Figure 20. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020

Figure 21. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2020

Figure 22. Global Oncology Drugs Revenue Market Share by Type (2016-2021)

Figure 23. Global Oncology Drugs Revenue Market Share by Type (2022-2027)

Figure 24. North America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. North America Oncology Drugs Market Share by Type (2016-2027)

Figure 26. North America Oncology Drugs Market Share by Application (2016-2027)

Figure 27. North America Oncology Drugs Market Share by Country (2016-2027)

Figure 28. United States Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 29. Canada Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 30. Europe Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. Europe Oncology Drugs Market Share by Type (2016-2027)

Figure 32. Europe Oncology Drugs Market Share by Application (2016-2027)

Figure 33. Europe Oncology Drugs Market Share by Country (2016-2027)

Figure 34. Germany Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. France Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. U.K. Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. Italy Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 38. Russia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 39. Nordic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 40. Asia-Pacific Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Asia-Pacific Oncology Drugs Market Share by Type (2016-2027)

Figure 42. Asia-Pacific Oncology Drugs Market Share by Application (2016-2027)

Figure 43. Asia-Pacific Oncology Drugs Market Share by Region (2016-2027)

Figure 44. China Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Japan Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. South Korea Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. Southeast Asia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 48. India Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 49. Australia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 50. Latin America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Latin America Oncology Drugs Market Share by Type (2016-2027)

Figure 52. Latin America Oncology Drugs Market Share by Application (2016-2027)

Figure 53. Latin America Oncology Drugs Market Share by Country (2016-2027)

Figure 54. Mexico Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 55. Brazil Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 56. Middle East & Africa Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Middle East & Africa Oncology Drugs Market Share by Type (2016-2027)

Figure 58. Middle East & Africa Oncology Drugs Market Share by Application (2016-2027)

Figure 59. Middle East & Africa Oncology Drugs Market Share by Country (2016-2027)

Figure 60. Turkey Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 61. Saudi Arabia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 62. UAE Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 63. Roche Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 64. Celgene Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 65. Novartis Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 68. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 69. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 70. Pfizer Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 71. Amgen Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 72. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 73. AbbVie Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 74. Takeda Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 75. Astellas Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 76. Ipsen Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 77. Sanofi Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 78. Bayer Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 79. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 80. Teva Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 81. Otsuka Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 82. Eisai Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 83. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2016-2021)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Oncology Drugs Market Size, Status and Forecast 2021-2027

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oncology Drugs Market Size, Status and Forecast 2021-2027

Published Date: June 2021

Report Code: QYRE-Auto-4R430

Global Oncology Drugs Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-4R430

Report

June 2021

125 Pages

QYResearch

Region: Global, Central & South America, North America, Europe, Asia Pacific, Middle East, Africa,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY REGION

BY COMPANY

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$3900

Multi User

Electronic (PDF)

$5850

Enterprise User

Electronic (PDF)

$7800

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-37B11450

Fri Aug 12 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-39E11527

Fri Aug 12 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-29D11405

Fri Aug 12 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-18X11631

Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions